YU47735B - Postupak za sintezu biološki aktivnih polipeptida limfotoksina - Google Patents

Postupak za sintezu biološki aktivnih polipeptida limfotoksina

Info

Publication number
YU47735B
YU47735B YU91985A YU91985A YU47735B YU 47735 B YU47735 B YU 47735B YU 91985 A YU91985 A YU 91985A YU 91985 A YU91985 A YU 91985A YU 47735 B YU47735 B YU 47735B
Authority
YU
Yugoslavia
Prior art keywords
lymphotoxin
nucleic acid
polypeptides
synthesis
procedure
Prior art date
Application number
YU91985A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU91985A (en
Inventor
B.B. Aggarwal
T.S. Bringman
P.W. Gray
G.E. Nedwin
Original Assignee
Genentech Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech Inc. filed Critical Genentech Inc.
Publication of YU91985A publication Critical patent/YU91985A/xx
Publication of YU47735B publication Critical patent/YU47735B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
YU91985A 1984-05-31 1985-05-31 Postupak za sintezu biološki aktivnih polipeptida limfotoksina YU47735B (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US73231285A 1985-05-09 1985-05-09

Publications (2)

Publication Number Publication Date
YU91985A YU91985A (en) 1988-12-31
YU47735B true YU47735B (sh) 1996-01-08

Family

ID=27417179

Family Applications (1)

Application Number Title Priority Date Filing Date
YU91985A YU47735B (sh) 1984-05-31 1985-05-31 Postupak za sintezu biološki aktivnih polipeptida limfotoksina

Country Status (23)

Country Link
EP (2) EP0509553B1 (OSRAM)
JP (3) JP2521703B2 (OSRAM)
AR (1) AR245219A1 (OSRAM)
AT (2) ATE195323T1 (OSRAM)
AU (1) AU599303B2 (OSRAM)
BG (1) BG60256B1 (OSRAM)
CA (1) CA1340641C (OSRAM)
CZ (1) CZ283148B6 (OSRAM)
DE (2) DE3588225T2 (OSRAM)
DK (1) DK171531B1 (OSRAM)
ES (1) ES8802182A1 (OSRAM)
FI (1) FI93025C (OSRAM)
GR (1) GR851317B (OSRAM)
HU (1) HU204085B (OSRAM)
IE (1) IE63487B1 (OSRAM)
IL (1) IL75318A (OSRAM)
NO (1) NO179075C (OSRAM)
NZ (1) NZ212207A (OSRAM)
PL (1) PL155410B1 (OSRAM)
PT (1) PT80573B (OSRAM)
RO (1) RO100383A2 (OSRAM)
SK (1) SK393085A3 (OSRAM)
YU (1) YU47735B (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860001471B1 (ko) 1980-04-03 1986-09-26 비오겐 엔. 브이 인체의 섬유아세포 인터페론(IFN-β)폴리펩티드의 제조방법
IL75318A (en) 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
ATE73856T1 (de) * 1984-12-21 1992-04-15 Biogen Inc Reinigung, herstellung und verwendung von tumor- nekrosisfaktoren.
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
DE3686148T2 (de) * 1985-12-24 1993-01-14 Denki Kagaku Kogyo Kk Lymphotoxin-gen, verfahren zu dessen herstellung und lymphotoxin.
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
JP2636862B2 (ja) * 1986-12-24 1997-07-30 武田薬品工業株式会社 組み換え型ヒトリンホトキシン
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
EP0813423B1 (en) * 1995-01-23 2002-07-03 Xenotech Incorporated Composition to inhibit osteolysis and metastasis
US5925351A (en) * 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
ES2316182T3 (es) 1998-01-15 2009-04-01 Genentech, Inc. Ligando apo-2.
WO2004047728A2 (en) * 2002-11-26 2004-06-10 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2529945A1 (en) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
WO2005067477A2 (en) * 2003-12-08 2005-07-28 Centocor, Inc. Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
WO2005092927A1 (en) 2004-03-23 2005-10-06 Biogen Idec Ma Inc. Receptor coupling agents and therapeutic uses thereof
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
PE20080980A1 (es) * 2006-10-12 2008-09-02 Genentech Inc Anticuerpos anti-linfotoxina alfa
CA2666934A1 (en) 2006-10-20 2008-04-24 Biogen Idec Ma Inc. Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
BR112016024841A2 (pt) * 2014-04-25 2017-10-24 Naurex Inc composições estáveis de peptídeos neuroativos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192465A (en) * 1978-12-22 1983-09-30 Biogen Nv Recombinant dna molecule comprising gene coding for polypeptide displaying hbv (hepatitis b virus) antigenicity usesthereof
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
IL75318A (en) 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production

Also Published As

Publication number Publication date
IE63487B1 (en) 1995-05-03
ATE95243T1 (de) 1993-10-15
CA1340641C (en) 1999-07-13
NO852173L (no) 1985-12-02
CZ283148B6 (cs) 1998-01-14
JP2804237B2 (ja) 1998-09-24
AR245219A1 (es) 1993-12-30
JPH07291995A (ja) 1995-11-07
JPS6156197A (ja) 1986-03-20
HU204085B (en) 1991-11-28
ATE195323T1 (de) 2000-08-15
JPH07250692A (ja) 1995-10-03
DE3588225T2 (de) 2001-04-05
SK278333B6 (en) 1996-11-06
EP0164965B1 (en) 1993-09-29
FI93025C (fi) 1995-02-10
IE930589L (en) 1985-11-30
FI852143A0 (fi) 1985-05-29
GR851317B (OSRAM) 1985-11-25
CZ393085A3 (en) 1997-07-16
DK241385D0 (da) 1985-05-30
ES543695A0 (es) 1988-04-16
ES8802182A1 (es) 1988-04-16
EP0164965A3 (en) 1988-04-06
FI852143L (fi) 1985-12-01
NO179075B (no) 1996-04-22
IL75318A (en) 1994-08-26
SK393085A3 (en) 1996-11-06
DE3587597D1 (de) 1993-11-04
DE3588225D1 (de) 2000-09-14
IL75318A0 (en) 1985-09-29
BG60256B2 (bg) 1994-03-24
IE851321L (en) 1985-11-30
NO179075C (no) 1996-07-31
DK171531B1 (da) 1996-12-23
DK241385A (da) 1985-12-01
DE3587597T2 (de) 1994-06-01
JP2521703B2 (ja) 1996-08-07
RO100383B1 (ro) 1991-03-01
NZ212207A (en) 1991-07-26
HUT37814A (en) 1986-02-28
PL155410B1 (en) 1991-11-29
PT80573A (en) 1985-06-01
YU91985A (en) 1988-12-31
PT80573B (pt) 1987-08-19
EP0509553B1 (en) 2000-08-09
RO100383A2 (ro) 1991-10-17
PL253739A1 (en) 1986-03-11
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
AU599303B2 (en) 1990-07-19
EP0509553A1 (en) 1992-10-21
FI93025B (fi) 1994-10-31
EP0164965A2 (en) 1985-12-18

Similar Documents

Publication Publication Date Title
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
DE69434083D1 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DE3686397D1 (de) Kovalent gebundene polypeptid enthaltende zellmodulatoren.
DE69112207D1 (en) "walk-through"-mutagenese.
DK0559884T3 (da) Rekombinante virusvektorer til ekspression i muskelceller
DK161152C (da) Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
CY1108175T1 (el) ΠΟΛΥΠΕΠΤΙΔΙΟ DcR3, ΟΜΟΛΟΓΟ TNFR
UA27706C2 (uk) Спосіб одержання гетерологічного поліпептиду
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
ES8306797A1 (es) Un metodo para producir un polipeptido.
DE68905633D1 (de) Markierer der t-zelle aktivierung.
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
BG101408A (bg) Аналози на кератиноцитния растежен фактор
PT666914E (pt) Nova proteina ligando da selectina p
DK1032672T3 (da) DNA19355-polypeptid, en tumornekrosefaktor-homolog
DE69433107D1 (de) Rekombinante dnase b aus streptococcus pyogenes
NO174970C (no) Rekombinant DNA, rekombinant DNA-vektor samt vertscelle
DE3581336D1 (de) Polypeptid verwandt mit alpha-hanp.
GB8616219D0 (en) Monoclonal antibodies
FI841288A7 (fi) Rekombinaatti-DNA-koodaus polypeptidin ilmaisemiseksi.
DE3583245D1 (de) Herstellung von aminosaeuren durch biologischen austausch.
DE69433902D1 (de) Neuartige tyrosinkinase
ATE102957T1 (de) Peptidstrukturen, sie enthaltende immunogene und deren anwendung zur kontrolle der fertilitaet.